Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-28

FDA Approved: EPINEPHRINE — Supplemental Application (BPI Labs, LLC)

View source ↗

Summary

The FDA has approved a supplemental application for epinephrine filed by BPI Labs, LLC under the existing NDA. The approval authorizes changes to the product pe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPINEPHRINE (EPINEPHRINE)

Snippet

SUPPL AP for EPINEPHRINE (EPINEPHRINE)